For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, General Manager,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/
Daiichi Sankyo to Launch Memary(R) 5mg, 10mg and 20mg Tablets for the Treatment of Alzheimer’s Disease
TOKYO, Japan (April 27, 2011) － Daiichi Sankyo Company, Limited today announced that it will launch Memary® 5mg, 10mg and 20mg Tablets (generic name: Memantine Hydrochloride, Approval to Manufacture and Market: January 21) given once daily for the treatment of moderate to severe Alzheimer's Disease on Wednesday, June 8.
The launch in Japan of Memary® had previously been postponed on March 16 following the Tohoku Pacific Offshore Earthquake.
End